Alzheimer’s Disease

To evaluate if a new investigational drug is safe and effective in improving
symptoms of mild to moderate Alzheimer’s disease.

You or someone you know may be eligible if you:

♦ Are between 55 and 85 years of age
♦ Have been diagnosed with Alzheimer’s
disease
♦ Have a reliable support person or caregiver
who is willing to participate in study visits,
report on daily activities and oversee or
help you with taking ATH-1017

  • * Required Field

    Submission of this form does not guarantee your enrollment in any study, but it does let us know you have an interest in participating.

  • This field is for validation purposes and should be left unchanged.